ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Internal Medicine

Top Internal Medicine Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SYED KAZMI M.D.

Internal Medicine

11,279

$674K

452
306 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $61

MARK HEAD MD

Internal Medicine

11,205

$641K

397
316 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $61

ERIC WYMER MD

Internal Medicine

11,203

$770K

504
436 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$69
Average prescription price

Avg: $61

JOHN ALLEGA M.D.

Internal Medicine

11,177

$549K

475
396 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $61

JOSEPH MUNNING M.D.

Internal Medicine

11,155

$514K

437
376 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $61

PETER BLANKENHORN MD

Internal Medicine

11,148

$664K

558
509 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $61

WARD NEFF M.D.

Internal Medicine

11,125

$760K

478
399 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $61

JAMES WALSH MD

Internal Medicine

11,078

$651K

591
527 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $61

PAUL BERGFELDER MD

Internal Medicine

10,996

$525K

524
456 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

25%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $61

STEVEN MOOIBROEK M.D.

Internal Medicine

10,986

$897K

588
507 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$82
Average prescription price

Avg: $61

JANE BLINZLER MD

Internal Medicine

10,980

$564K

371
264 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $61

THOMAS GIBSON MD

Internal Medicine

10,939

$647K

422
346 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

24%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $61

MARK TIRITILLI

Internal Medicine

10,896

$673K

459
197 are 65+

17%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 16%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $61

BACHAR MALEK M.D.

Internal Medicine

10,873

$628K

384
186 are 65+

27%
patients receiving schedule two controlled substances

Avg: 6%

39%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $61

CHRISTOPHER IORIO MD

Internal Medicine

10,829

$800K

513
418 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$74
Average prescription price

Avg: $61

JOY STONE M.D.

Internal Medicine

10,708

$684K

434
357 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $61

PATRICK ANDERSON M.D.

Internal Medicine

10,694

$575K

607
511 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $61

GRACE FOWLER DO

Internal Medicine

10,665

$602K

273
199 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $61

MIRZA RAHEEM M.D.

Internal Medicine

10,458

$650K

405
360 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $61

RYAN HOUGHTON MD

Internal Medicine

10,447

$526K

464
344 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $61

JEROME SKELLY M.D.

Internal Medicine

10,442

$669K

455
419 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $61

JOSEL MIJARES M.D.

Internal Medicine

10,426

$602K

286
187 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $61

SYED ALI MD

Internal Medicine

10,358

$535K

318
253 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

25%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $61

STEPHEN BECK M.D.

Internal Medicine

10,249

$646K

473
394 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $61

JAMES PICKFORD MD

Internal Medicine

10,242

$639K

443
391 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank